Galapagos NV (GLPGF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD

24.66

-24.04

(-49.36%)

As of 03:00PM EST. Market open.

Loading interactive chart...

GlobeNewswire
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell therapy manufacturing platform delivers fresh, fit cells within a median vein-to-vein time of seven days, with potentially encouraging patient outcomes. Three abstracts, including one oral presentation for GLPG5101 in relapsed/refractory non-Hodgkin lymphoma, and a company showcase, will spotlight our c
Simply Wall St.
Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)
Galapagos ( AMS:GLPG ) Third Quarter 2024 Results Key Financial Results Revenue: €59.8m (down 50% from 3Q 2023). Net...